Prevalence of metabolic bone disease among chronic rhinosinusitis patients treated with oral glucocorticoids.
Prevalence of metabolic bone disease among chronic rhinosinusitis patients treated with oral glucocorticoids. Am J Rhinol Allergy. 2010 May-Jun; 24(3):215-9.